E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
22 / 07 / 2020

 


Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India

Gandham Ravi, Gaurav Chikara, Arkapal Bandyopadhyay, Shailendra Handu.


Abstract
Background: Adverse drug reactions (ADRs) are not uncommon due to medications, especially antimicrobials (AMs), given to the patients during their stay in the hospital.

Aim and Objective: The present study aims to assess the ADRs related to AMs, causality assessment using the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) causality assessment scale and the Naranjo scale and to evaluate their agreement.

Materials and Methods: A prospective, observational study conducted over a period of one year in general medicine and pulmonary medicine wards, including 206 patients. WHO-UMC scale and the Naranjo algorithm were used to assess the causality followed by evaluating the agreement between these two scales.

Results: The most common antibiotic accounted for ADRs was Piperacillin+Tazobactam (36.10%). The most common organ system involved was gastrointestinal (83.30%), followed by skin and soft tissue (11.10%) and immunological (5.60%). While 58.30% of the ADRs were latent in onset, 30.60% and 11.10% were sub-acute and acute, respectively. The majority of the ADRs were mild (66.70%), followed by moderate (22.20%) and severe (11.10%) in nature. As per the WHO-UMC scale, 19.4% ADRs were certain, 47.2% were probable, 27.8% were possible, and 5.6% were found to be unlikely. As per Naranjo algorithm, 75% of the ADRs were probable and 25% were of possible. Overall agreement analysis showed “Poor” agreement between the WHO-UMC scale and the Naranjo algorithm (kappa statistics with 95% confidence interval = 0.2195 [0.0065, 0.4325]).

Conclusion: Using both the WHO-UMC scale and the Naranjo algorithm is advisable for better evaluation of ADRs related to AMs.

Key words: Antimicrobials; Agreement; World Health Organization-UMC Scale; Naranjo Scale; Causality Assessment


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Gandham Ravi
Articles by Gaurav Chikara
Articles by Arkapal Bandyopadhyay
Articles by Shailendra Handu
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ravi G, Chikara G, Bandyopadhyay A, Handu S. Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. Natl J Physiol Pharm Pharmacol. 2020; 10(11): 945-949. doi:10.5455/njppp.2020.10.06170202012072020


Web Style

Ravi G, Chikara G, Bandyopadhyay A, Handu S. Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. https://www.njppp.com/?mno=119277 [Access: March 14, 2024]. doi:10.5455/njppp.2020.10.06170202012072020


AMA (American Medical Association) Style

Ravi G, Chikara G, Bandyopadhyay A, Handu S. Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. Natl J Physiol Pharm Pharmacol. 2020; 10(11): 945-949. doi:10.5455/njppp.2020.10.06170202012072020



Vancouver/ICMJE Style

Ravi G, Chikara G, Bandyopadhyay A, Handu S. Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. Natl J Physiol Pharm Pharmacol. (2020), [cited March 14, 2024]; 10(11): 945-949. doi:10.5455/njppp.2020.10.06170202012072020



Harvard Style

Ravi, G., Chikara, . G., Bandyopadhyay, . A. & Handu, . S. (2020) Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. Natl J Physiol Pharm Pharmacol, 10 (11), 945-949. doi:10.5455/njppp.2020.10.06170202012072020



Turabian Style

Ravi, Gandham, Gaurav Chikara, Arkapal Bandyopadhyay, and Shailendra Handu. 2020. Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. National Journal of Physiology, Pharmacy and Pharmacology, 10 (11), 945-949. doi:10.5455/njppp.2020.10.06170202012072020



Chicago Style

Ravi, Gandham, Gaurav Chikara, Arkapal Bandyopadhyay, and Shailendra Handu. "Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 945-949. doi:10.5455/njppp.2020.10.06170202012072020



MLA (The Modern Language Association) Style

Ravi, Gandham, Gaurav Chikara, Arkapal Bandyopadhyay, and Shailendra Handu. "Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India." National Journal of Physiology, Pharmacy and Pharmacology 10.11 (2020), 945-949. Print. doi:10.5455/njppp.2020.10.06170202012072020



APA (American Psychological Association) Style

Ravi, G., Chikara, . G., Bandyopadhyay, . A. & Handu, . S. (2020) Antimicrobial-associated adverse drug reaction profiling and assessing the agreement between the WHO-UMC scale and the Naranjo algorithm for causality assessment at a tertiary care teaching hospital in India. National Journal of Physiology, Pharmacy and Pharmacology, 10 (11), 945-949. doi:10.5455/njppp.2020.10.06170202012072020